FebriDx Update - Brazil Market Authorisation & New Study
Filed with ASX · · 3 pages · English
Lumos Diagnostics Holdings Ltd. on 6ix
Earlier from Lumos Diagnostics
- FY2022 Half Year Update
- Lumos Diagnostics FY22 First Half Year Results
- Change To Lumos Board
- Victorian Government Intent for Lumos Manufacturing Hub
- Over 100 Pharmacies in Liverpool UK Launch FebriDx Service
Later from Lumos Diagnostics
- Operational Review & Management Reorganisation
- Operational Update and Accelerated Entitlement Offer
- Target Market Determination
- Successful Completion of Institutional Entitlement Offer
- Lumos secures initial development services contract
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics